1. P263 Influence of Crohn′s Disease phenotype in the retention rate of ustekinumab treatment: SUSTAIN Study. (27th May 2021) Authors: Chaparro, M; Bastón Rey, I; Fernández-Salgado, E; González García, J; Ramos, L; Diz-Lois Palomares, M T; Argüelles, F; Iglesias Flores, E; Cabelo, M; Rubio Iturria, S; Núñez Ortiz, A; Charro, M; Ginard, D; Dueñas Sadornil, C; Merino Ochoa, O; David, B; Iyo, E; Gutiérrez Casbas, A; Ramírez de la P... Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P439 Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registry. (25th January 2019) Authors: Casanova, M J; Chaparro, M; Mínguez, M; Ricart, E; Taxonera, C; García-López, S; Guardiola, J; López-San Román, A; Iglesias, E; Beltrán, B; Sicilia, B; Vera, M I; Hinojosa, J; Riestra, S; Domènech, E; Calvet, X; Pérez-Calle, J L; Martín-Arranz, M D; Aldeguer, X; Rivero, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P509 Influence of concomitant immunosuppresives in retention rate in Crohn′s Disease patients under ustekinumab in the SUSTAIN Study. (27th May 2021) Authors: Chaparro, M; Bastón Rey, I; Fernández-Salgado, E; González García, J; Ramos, L; Diz-Lois Palomares, M T; Argüelles, F; Iglesias Flores, E; Cabello, M; Rubio Iturria, S; Núñez Ortiz, A; Charro, M; Ginard, D; Dueñas Sadornil, C; Merino Ochoa, O; Busquets, D; Iyo, E; Gutiérrez Casbas, A; Ramírez de ... Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗